The Nashville Tech Story (9/1/2009)
Your child or the one you love is running a dangerous fever and is showing signs that he/she may have contracted the ever dangerous H1N1 virus, better known as the “swine flu.” As you rush to the physician’s office your thoughts are constantly racing, hoping that it is just a run-of-the-mill virus. Having gone through this experience a few hours ago, the “what if” scenarios kept running through my mind as I rushed my daughter to the pediatrician. Once all was clear, I really had a moment to think about the implications if the test had shown a positive result.
The swine flu particularly in children can be deadly, but left untreated, could be deadly for anyone of us. The United States is one of the most technologically advanced societies in the world today, so what role does technology play to combat this potentially life threatening disease?
Being the hardest hit country in the world, a team of Australian scientists, along with the help of a federal grant from their government, has developed a new technology called the Nanopatch. This potentially could eliminate some of the major problems associated with the vaccination of millions worldwide. The goal of the Nanopatch project is to target long term protection, similar to that of the annual flu shot, which calls for seasonal vaccinations.
The patch ignites immune cells found under the surface of the skin. This, in turn, initiates a powerful immune response from the body, while using considerably less vaccine. Producing the Nanopatch is significantly cheaper than the use of a syringe or needle. The reduction in cost is based on the Nanopatch using less of the vaccine and the elimination of expensive syringes, needles, and the appropriate means of disposal.
While this new technology is still in the testing phase, the increase in reported H1N1 flu cases should drive the production of potential weapons to treat this virus to a new level. As the swine flu continues to make its best attempt to steal the headlines, the common seasonal flu symptoms now take priority in early treatment and detection. As in Australia, the use of the Nanopatch and the hope that the United States will see some relief could still be a few years away.